BRIEF published on 11/17/2025 at 09:10, 8 months 23 days ago The Platform Group AG's Ambitious Vision for 2030 Revenue Growth First Berlin Equity Research The Platform Group AG AEBITDA Margin 2030 Vision
PRESS RELEASE published on 11/17/2025 at 09:05, 8 months 23 days ago Original-Research: The Platform Group AG (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research updates recommendation on The Platform Group AG to Buy with a target price of €20 by 2030. Detailed analysis on company's long-term goals and revenue growth strategy Revenue Growth First Berlin Equity Research Buy Recommendation The Platform Group AG 2030 Vision
BRIEF published on 11/14/2025 at 09:40, 8 months 26 days ago Platform Group AG vise la croissance avec sa Vision 2030 Rentabilité Stratégie De Croissance The Platform Group AG Évaluation Des Actions Vision 2030
BRIEF published on 11/14/2025 at 09:40, 8 months 26 days ago The Platform Group AG Targets Growth with Vision 2030 Growth Strategy Profitability Stock Valuation The Platform Group AG Vision 2030
PRESS RELEASE published on 11/14/2025 at 09:35, 8 months 26 days ago Original-Research: The Platform Group AG (von NuWays AG): Buy The Platform Group AG, a German company, announces Vision 2030 goals focusing on KPI improvement and margin expansion. The stock is deemed undervalued with a PT of EUR 21.00 The Platform Group AG Margin Expansion Vision 2030 Undervalued PT EUR 21.00
BRIEF published on 11/12/2025 at 08:20, 8 months 28 days ago Platform Group AG dévoile sa Vision 2030 assortie d'objectifs de croissance ambitieux. Expansion Internationale Croissance Des Revenus Intégration De L'IA Stratégie De Fusions Et Acquisitions Augmentation De La Marge
BRIEF published on 11/12/2025 at 08:20, 8 months 28 days ago The Platform Group AG Unveils Vision 2030 with Ambitious Growth Goals AI Integration Revenue Growth M&A Strategy International Expansion Margin Increase
PRESS RELEASE published on 11/12/2025 at 08:15, 8 months 28 days ago The Platform Group publishes Vision 2030: EUR 3 billion in revenue, significant margin increase, and growth to 40,000 partners The Platform Group AG unveils Vision 2030: EUR 3 billion revenue target, double-digit margins, and expansion to 40,000 partners by 2030 The Platform Group AG Revenue Target Vision 2030 Double-digit Margins Partner Expansion
BRIEF published on 11/10/2025 at 10:34, 9 months ago The Platform Group AG's Growth Trajectory: A Positive Outlook EBITDA Margin Sales Growth Q3 Results Platform Group AG Consumer Goods
BRIEF published on 11/10/2025 at 10:34, 9 months ago Trajectoire de croissance de Platform Group AG : des perspectives positives Croissance Des Ventes Marge D'EBITDA Résultats Du Troisième Trimestre Groupe Platform AG Biens De Consommation
Published on 08/10/2026 at 08:00, 2 hours 37 minutes ago Galantas Gold Expands Indiana Drill Program to 12,500 Metres
Published on 08/10/2026 at 08:00, 2 hours 37 minutes ago Results of AGM and Management Update Presentation
Published on 08/07/2026 at 23:15, 2 days 11 hours ago Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 2 days 11 hours ago Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/10/2026 at 10:12, 25 minutes ago Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Published on 08/10/2026 at 10:10, 27 minutes ago Hana Bank Subsidiary GLN Expands QR Payment Network for International Travelers to Korea
Published on 08/10/2026 at 09:50, 47 minutes ago Photon Energy N.V. Bond 21/27 (ISIN: DE000A3KWKY4): Signs of a crisis are mounting. What can investors do? Invitation to video conferences (German/English)
Published on 08/10/2026 at 09:00, 1 hour 37 minutes ago Original-Research: Rosenbauer International AG (von NuWays AG): BUY
Published on 08/10/2026 at 09:00, 1 hour 37 minutes ago Original-Research: Bittium Oyj (von NuWays AG): BUY
Published on 08/10/2026 at 09:22, 1 hour 15 minutes ago Number of shares and voting rights - July 2026 (In French only)
Published on 08/10/2026 at 09:22, 1 hour 15 minutes ago Nombre total d'actions et droits de vote - juillet 2026
Published on 08/10/2026 at 07:00, 3 hours 37 minutes ago BIOPHYTIS ANNOUNCES APPROVAL OF THE OBA CLINICAL TRIAL IN BRAZIL AND SHARES ITS OUTLOOK FOR BIO101 IN OBESITY
Published on 08/10/2026 at 07:00, 3 hours 37 minutes ago Biophytis annonce l’autorisation de l’étude clinique OBA au Brésil et partage les perspectives de BIO101 dans l’obésité
